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Abstract
Creatine kinase (CK) plays a crucial role in myocardial energy metabolism. Alterations in CK gene expression are found in
hypertrophied and failing heart, but the mechanisms behind these changes are unclear. This study tests the hypothesis that
increased adrenergic stimulation, which is observed in heart failure, induces changes of myocardial CK-activity, -isoenzyme
distribution and -gene expression that are characteristic of the failing and hypertrophied heart. Isolated rat hearts were
perfused (constant pressure of 80 mmHg) with red cell suspensions. Following a 20-min warm-up period, perfusion for 3 h
with 1038 M (iso 3 h) or without (control 3 h) isoproterenol was started or experiments were immediately terminated (control
0 h). Left ventricular tissue was analyzed for total CK-activity, CK-isoenzyme distribution and, by use of quantitative RT^
PCR, for B-CK, M-CK, mito-CK and GAPDH- (as internal standard) mRNA. After L-adrenergic stimulation (iso 3 h) but
not after control perfusion (control 3 h) a roughly threefold increase in B-CK mRNA levels and a decrease in M-CK mRNA
levels by 18% was found. There were no significant differences among the three groups in total CK-activity and in
distribution of CK-MM, CK-BB, CK-MB and mito-CK. Thus, L-adrenergic stimulation induces a switch in CK gene
expression from M-CK to B-CK, which is characteristic for the hypertrophied and failing heart. This may be interpreted as
an adaptive mechanism making energy transduction via CK more efficient at times of increased metabolic demand. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Creatine kinase (CK, ATP; creatine N-phospho-
transferase, EC 2.7.3.2), which catalyzes the phos-
phoryl exchange between ADP and creatine, is highly
expressed in the myocardium [1]. It plays a crucial
role in myocardial energy metabolism and in energy
transduction from the sites of ATP production to the
sites of ATP utilization [2]. The CK gene family
codes for four subunit CK isoforms, that are ex-
pressed in a tissue-speci¢c manner [2]. There are
two cytosolic forms, M-CK and B-CK, and two mi-
tochondrial forms [3^6]. M-CK and B-CK subunits
combine to form the dimeric cytosolic isoenzymes,
MM-, MB- and BB-CK [2]. A developmental transi-
tion from BB- via MB- to the MM-CK is found
during muscle cell di¡erentiation [3]. The mitochon-
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drial isoforms occur mostly as octamers. Two dis-
tinct mitochondrial CK isoenzymes exist, ubiquitous
and a sarcomeric mito-CK [7,8], but in heart all
mito-CK activity arises from the sarcomeric isoform.
Changes in myocardial CK isoenzyme distribution
and/or CK gene expression have been reported for
left ventricular hypertrophy and/or failure induced
by pressure overload [9^12], volume overload [13],
in heart failure due to rapid pacing [14], LAD occlu-
sion [15,16] or mitral regurgitation [17]. The mecha-
nisms by which hemodynamic alterations in these
animal models evoke changes in CK gene expression
and isoenzyme distribution are not completely under-
stood.
Left ventricular hypertrophy and failure are
closely related to adrenergic stimulation. General ac-
tivation of the sympathetic nervous system occurs in
heart failure [18], resulting in increased plasma con-
centrations of norepinephrine [19]. A close correla-
tion between norepinephrine levels and mortality has
been reported. Increased release of norepinephrine
[20] and reduced myocardial norepinephrine stores
[21] are both found in patients with heart failure.
Furthermore, L- as well as K-adrenergic stimulation
cause hypertrophy and induction of proto-oncogenes
in myocyte cell culture [22,23], in isolated hearts [24]
and in the in vivo heart of several animal species
[25,26].
The present study examines the hypothesis that
acute L-adrenergic stimulation, which is known to
induce proto-oncogene induction and subsequent hy-
pertrophy, also mediates changes in CK isoenzyme
distribution. Using an isolated erythrocyte suspen-
sion perfused Langendor¡ rat heart model, the ef-
fects of acute L-adrenergic stimulation on CK isoen-
zyme distribution and gene expression can be studied
without in£uence of any other neurohumoral mech-
anisms that may be activated in a whole animal mod-
el.
2. Materials and methods
2.1. Isolated red blood cell perfused rat heart
2.1.1. Animals and isolated heart preparation
Male Wistar rats (ca. 300 g) were obtained from
Charles River Laboratories (KiMlegg, Germany).
Rats were anesthetized by intraperitoneal injection
of 10 mg/100 g body weight pentobarbital sodium.
One hundred IU heparin were injected intravenously.
The thorax was rapidly opened. The heart was ex-
cised and placed into ice-cold bu¡er. The aorta was
dissected and the heart was subjected to retrograde
perfusion with erythrocyte suspension via the aortic
cannula of the perfusion apparatus. The perfusion
pressure was set to 80 mmHg. Less than 30 s elapsed
between opening of the thorax and initiation of per-
fusion. A small vent was inserted into the left ven-
tricular apex to drain the £ow from Thebesian veins.
A second vent was placed into the right ventricle via
the pulmonary artery to drain coronary circulation.
A water-¢lled latex balloon was inserted into the left
ventricle through an incision in the left atrial append-
age, via the mitral valve and secured by a ligature.
The balloon was connected to a pressure transducer
(Statham P23Db Gould Instruments, Glen Burnie,
MD) via a small bore polyethylene tubing for con-
tinuous recording of left ventricular pressure and
heart rate. Coronary £ow, heart rate and left ventric-
ular pressure were continuously recorded. The heart
was placed in a water-jacketed constant temperature
chamber and maintained at 37‡C. The experiments
were started after a 20-min stabilization period.
2.1.2. Continuous pressure perfusion system
The perfusion system consisted of a water-jacketed
‘venous reservoir’, a variable £ow pump, an oxygen-
ator, a water-jacketed ‘arterial reservoir’ and a 20-
Wm pore size ¢lter. The oxygenator consisted of semi-
permeable tubes which allow gas equilibration. The
perfusate was equilibrated with a gas mixture of N2,
O2 and CO2 (77%, 20% and 3%, respectively). The
gases were adjusted to achieve perfusate pO2 of 120^
140 mmHg and perfusate pH between 7.37 and 7.43.
Blood gas analysis was performed every 15 min
(ABL 30, Radiometer, Copenhagen, Denmark). Per-
fusion pressure was adjusted by varying the height of
the ‘arterial reservoir’ and monitored via a side arm
of the aortic cannula with a pressure transducer
(Statham P23Db; Gould Instruments).
2.1.3. Preparation and storage of bovine erythrocytes
Fresh whole cow blood was obtained from a local
slaughterhouse. Blood was collected from the jugular
veins. Immediately after collection 0.25 vol. of a sta-
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bilization solution containing sodium citrate 50 mM,
citric acid 23 mM and glucose 74 mM as well as
heparin 7500 IU/l and tobramycin 20 mg/l were
added to prevent coagulation, hemolysis and bacte-
rial growth. This mixture was transported on ice and
was centrifuged at 4‡C and 2500Ug for 20 min. The
supernatant consisting of plasma and bu¡y coat was
discarded. The packed cells were washed twice with
1 vol. of 10 mM phosphate-bu¡ered isotonic sodium
chloride solution and twice with 1 vol. of Krebs^
Henseleit bu¡er. Finally, erythrocytes were resus-
pended in 1 vol. storage solution containing sodium
chloride 151 mM, glucose 45 mM, mannitol 29 mM
and adenine 0.25 mM. Ten mg/l tobramycin was
added. This suspension was stored at 4‡C for no
longer than 6 days.
2.1.4. Perfusate preparation
The perfusate was prepared daily. The suspension
of erythrocytes and storage solution was centrifuged
for 10 min, 2500Ug at 4‡C. The packed cells were
washed with Krebs^Henseleit bu¡er and then resus-
pended with a modi¢ed Krebs^Henseleit bu¡er con-
taining additional 40 g/l fatty acid-free bovine serum
albumin, glucose 5.5 mM, pyruvate 2.2 mM, and
tobramycin 20 mg/l, which was passed through a
0.45-Wm Millipore ¢lter. The hematocrit was adjusted
to 40% and the concentration of free calcium to 1.1
mM.
2.2. Total creatine kinase activity and creatine kinase
isoenzyme distribution
Intact left ventricular tissue (5^10 mg) was homog-
enized in 0.1 M phosphate bu¡er (pH 7.4) containing
1 mM EGTA and 1 mM L-mercaptoethanol. Ali-
quots for measurement of protein content [27] were
taken. 0.1% Triton X was added. Samples were kept
on ice. Total CK activity was measured using an
Ultraspec III spectrophotometer (Pharmacia Biosys-
tems, Freiburg, Germany) as previously described
[16]. CK isoenzymes were separated using the Rapid
Electrophoresis System (REP, Helena Diagnostika)
as a separation unit. The REP CK Isoforms kit
was used for agarose gel and incubation solution.
The Electrophoresis Data Center (EDC, Helena Di-
agnostika) automatically quanti¢ed the isoenzyme
bands. This way the relative activities of the isoen-
zymes were determined simultaneously. Since the
speci¢c activities of the isoenzymes are similar, rela-
tive activities correspond to relative enzyme concen-
trations.
2.3. Quanti¢cation of creatine kinase mRNA (reverse
transcription^polymerase chain reaction)
Quanti¢cation of mRNA was performed by use of
the methods which were previously described [16].
2.3.1. RNA preparation
RNA from frozen left ventricular tissue was pre-
pared using the TRIZOL Reagent (GibcoBRL Life
Technologies, Eggenstein, Germany) according to
the single-step RNA isolation method [28]. In brief,
frozen left ventricular tissue was placed in 1 ml of
ice-cold TRIZOL reagent and homogenized with a
polytron device for 30 s. After 5 min incubation at
room temperature 0.2 ml chloroform was added. The
samples were centrifuged (15 min, 4‡C, 12 000Ug)
after 3 min incubation at room temperature. The
aqueous phase was transferred into a fresh tube.
RNA precipitation was performed with 1.5 ml iso-
propyl alcohol. After centrifugation (10 min, 4‡C,
12 000Ug), the RNA was washed with 2 ml 75%
ethanol. The RNA pellet (after centrifugation 5 min,
room temperature, 7500Ug) was then dissolved in
20 Wl water. The RNA concentration was determined
spectrophotometrically, and the purity and quality of
RNA was checked by measuring the ratio of the
absorption at 260 and 280 nm, which was 1.8 to
2.0 in all cases, by determining the absorption spec-
tra, and by RNA electrophoresis using a denaturat-
ing 3-(N-morpholino)propanesulfonic acid (MOPS)
gel. The 260/280 nm ratio was 1.8^2.0 and typical
RNA spectra were found in all cases. The MOPS
gel demonstrated the characteristic three RNA
bands.
2.3.2. Reverse transcription (RT)
One Wg of total RNA was used for reverse tran-
scription into cDNA. Twenty pmol random hexam-
ers (Boehringer, Mannheim, Germany) were added,
the mixture was heated to 70‡C for 10 min and
chilled one ice. The ¢nal reaction volume of 20 Wl
contained 0.5 mM dNTP, 0.01 M DTT, 50 mM
Tris^HCl, 75 mM KCl, 3 mM MgCl2, 10 U RNAsin
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(Promega, Mannheim, Germany) and 100 U Super-
script II reverse transcriptase (GibcoBRL Life Tech-
nologies), pH 8.3. Reverse transcription was per-
formed at 42‡C for 60 min. Reactions containing
no reverse transcriptase were done as negative con-
trols.
2.3.3. Quantitative PCR reactions
Forward and reverse oligonucleotide primer pairs
were synthesized to match the sequence of the rat
M-, B-, sarcomeric CK [8,29] and glyceraldehyde
phosphate dehydrogenase (GAPDH) as a standard
[30]. The primer sequences and positions as well as
the expected product sizes and the annealing temper-
atures are summarized in Table 1.
The transcript obtained from 50 ng RNA (i.e.,
1/20 of the reverse transcribed cDNA) were used
for polymerase chain reaction (PCR) reactions. The
50 Wl reaction volume contained 0.8 WM of the re-
spective oligonucleotide primers, 2 U Taq DNA
polymerase (Boehringer), 300 WM dNTP, 10 mM
Tris^HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2.
0.3 WCi K-[32P]dCTP (Amersham Pharmacia Biotech,
Buckinghamshire, UK) were present for quanti¢ca-
tion of PCR products. A GeneAmp 2400 thermal
cycler (Perkin^Elmer, Weiterstadt, Germany) was
used. Denaturation was done at 94‡C for 15 s
(5 min ¢rst cycle). The following 15-s annealing
step was carried out at the temperature given in Ta-
ble 1. The temperature of the extension step (30^60 s,
10 min last cycle) was 72‡C. All samples were as-
sayed for each gene using a single master reaction
mixture. The reaction products were separated by
vertical 5% polyacrylamide gel electrophoresis. The
32P content of the appropriate PCR products was
determined with a Molecular Dynamics phosphoim-
ager.
RNA of all samples was reverse transcribed three
times. PCR reactions for each gene were done with
the transcript of each of the three transcriptions.
This way, each tissue sample was assayed for the
expression of each gene three times.
In all experiments, a template-free negative con-
trol, RNA template not subjected to reverse tran-
scription and known amounts of plasmids containing
the respective sequences were ampli¢ed to check the
accuracy and e⁄ciency of the PCR. The number of
cycles required to obtain a reproducible ampli¢cation
in the exponential range was determined for each
PCR product individually, as described earlier [31].
The cycle number, indicated in Table 1, was selected
to remain well within the exponential ampli¢cation
range. For each PCR product, the ampli¢cations oc-
curred with similar e⁄ciency and the products were
well within the linear range of curves with standard
amounts of tissue RNA as detailed by Engelhardt et
al. [32]. Each PCR was simultaneously performed in
all samples of all experimental groups (n = 21). The
activity of the PCR product of each sample was
counted using a phosphoimager. The activity of the
sample with the highest activity was set to 1. The
activity of the remaining samples was given as frac-
tion of 1 (relative activity). The relative activities of
three PCRs per gene (B-, M-, mito-CK and
GAPDH) were averaged. This way the averaged rel-
ative activity ranges between 0 and 1, independent
from the total mRNA content. The averaged relative
activities of the B-, M- and mito-CK-mRNA were
Table 1
Sequences of oligonucleotide primers and conditions used in quantitative PCR reactions
mRNA Orientation Primer sequence Position in
coding sequence
Distance
(bp)
Cycle
number
Annealing
temperature (‡C)
B-CK Forward 5P-GCCGCCATGCCCTTCTC-3P 89 807 28 58
Reverse 5P-CTTAGACTTGAAGAGAGTTTC-3P 896
M-CK Forward 5P-CCACAACAAGTTCAAGCTGAA-3P 113 773 22 60
Reverse 5P-AAGATCTCCTCAATCTTCTGC-3P 886
Mito-CK
(sarcomeric)
Forward 5P-CTGTGGGCATGGTGGCTG-3P 514 699 22 60
Reverse 5P-TGGCTGAGCTTTGGGATCC-3P 1213
GAPDH Forward 5P-GCTGCCTTCTCTTGTGACAAA-3P 55 531 21 60
Reverse 5P-CACGCCACAGCTTTCCAGA-3P 586
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related to the averaged relative activity of GAPDH-
mRNA. This way the mRNA levels of all CK-iso-
enzymes related to GAPDH mRNA represent a val-
ue which ranges between 0 and 1 and do not re£ect
absolute amounts of mRNA. It allows comparison of
mRNA content of each CK isoenzyme between the
experimental groups. It does not allow comparison
of total mRNA content between the di¡erent isoen-
zymes.
2.4. Experimental protocol
After a 20-min warm-up and stabilization period,
isoproterenol (¢nal perfusate concentration 1038 M,
n = 8) or vehicle solution (control, n = 7) were infused
over a period of 3 h. Isoproterenol was diluted in
Krebs^Henseleit bu¡er in a concentration of
1.01U1036 M. This solution was infused into the
perfusion line immediately proximal of the aortic
cannula. The infusion rate of the isoproterenol solu-
tion was adjusted every 15 s. automatically according
to the coronary £ow and set to 1/100 of the mea-
sured coronary £ow. This way the perfusate isopro-
terenol concentration was 1038 M. Krebs^Henseleit
bu¡er without isoproterenol was used for perfusion
in the control group. Left ventricular tissue was
washed in ice-cold saline solution and rapidly frozen
in liquid nitrogen for analysis after the 3 h recording
time (isoproterenol 3 h group and control 3 h group)
or for measurement of baseline values immediately
after the warm-up period at t = 0 (control 0 h group,
n = 6).
2.5. Statistical analysis
The data are given as mean þ S.E.M. Comparison
between experimental groups was performed by Stu-
dent’s t-test with Bonferroni correction.
3. Results
3.1. Mechanical function
Fig. 1 presents the time course of left ventricular
pressures, heart rate and coronary £ow. No signi¢-
cant di¡erences were observed among the three
groups for these parameters at t = 0. Left ventricular
end-diastolic pressure (about 10 mmHg) was con-
stant in the control group during the whole 3 h re-
cording time, indicating that no impairment of dia-
stolic relaxation occurred. Also, heart rate remained
constant at about 275 min31 throughout the experi-
ments. Left ventricular systolic pressure, left ventric-
ular developed pressure and coronary £ow of the
control 3 h group remained constant over the ¢rst
90 min. Thereafter, a continuous decrease was ob-
served. Left ventricular developed pressure and cor-
onary £ow pressure declined by 38% and 31% from
87 þ 4.9 mmHg and 3.9 þ 0.40 ml min31 (t = 0) to
Fig. 1. Mechanical function. Time course of left ventricular sys-
tolic and end-diastolic pressure (LVSP, LVEDP), of coronary
£ow (CF) and of heart rate (HR) of the control t = 3 h group
(control 3 h) and of the isoproterenol group (iso 3 h). The cor-
responding mean values of the control at t = 0 averaged
95.8 þ 6.5 mmHg, 10.1 þ 0.45 mmHg, 3.4 þ 0.4 ml min31 and
297.5 þ 23.6 min31.
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54 þ 1.3 mmHg and 2.7 þ 0.29 ml min31 after 3 h.
There was no myocardial lactate production and no
signi¢cant release of CK or alanine aminotransferase
into the perfusate, indicating that there was no an-
aerobic metabolism or severe tissue damage. The
start of isoproterenol administration caused a rapid
increase in heart rate to about 360 min31 and in left
ventricular systolic pressure to about 170 mmHg.
Heart rate remained elevated during the whole 3 h
recording time. Left ventricular systolic and devel-
oped pressures declined towards baseline values. As
in the control group, the left ventricular end-diastolic
pressure remained unchanged during the whole ex-
periment under isoproterenol stimulation. Also, there
was no lactate production and no release of CK or
alanine aminotransferase into the perfusate in the
isoproterenol group.
3.2. Wet-to-dry-weight ratio
Wet-to-dry-weight ratios averaged 4.47 þ 0.22,
4.64 þ 0.14 and 4.42 þ 0.36 in the control 0 h, control
3 h and in the isoproterenol 3 h groups. Thus, rele-
vant edema formation did not occur in this isolated
heart model over a time period of 3 h. These data
correspond to results of other studies using isolated
red cell perfused rat heart [33].
3.3. Total CK activity and isoenzyme distribution
Table 2 summarizes total tissue CK activity and
relative and absolute activities of CK isoenzymes.
Control values at t = 0 and after 3 h did not di¡er
signi¢cantly. Total CK activity (about 7 IU/mg pro-
tein) as well as isoenzyme distribution with V1%
BB-CK, 13^15% MB-CK, 47^48% MM-CK and
37^38% mito-CK are similar to previously reported
data [34,35]. Total CK activity as well as CK isoen-
zyme distribution remained unchanged in the control
3 h group, indicating stability of the preparation for
these parameters. Isoproterenol stimulation over 3 h
did not a¡ect total CK activity or isoenzyme distri-
bution.
Table 2
Total CK activity, CK isoenzyme distribution and CK isoenzyme activity
Control 0 h Control 3 h Iso 3 h
Total CK IU/mg protein 6.5 þ 0.4 7.5 þ 0.4 7.3 þ 0.7
BB-CK % 1.3 þ 0.2 1.4 þ 0.1 1.5 þ 0.2
MB-CK % 13.7 þ 0.9 14.6 þ 0.6 12.9 þ 0.3
MM-CK % 47.8 þ 1.4 47.2 þ 1.4 47.1 þ 0.7
mito-CK % 37.1 þ 1.6 36.8 þ 1.4 38.5 þ 0.9
B-CK IU/mg protein 0.53 þ 0.03 0.66 þ 0.04 0.58 þ 0.06
M-CK IU/mg protein 3.6 þ 0.3 4.1 þ 0.2 3.9 þ 0.3
Mito-CK IU/mg protein 2.4 þ 0.1 2.8 þ 0.1 2.8 þ 0.3
Fig. 2. PCR products of B-CK, M-CK, mito-CK, and GAPDH-mRNA obtained from a control t = 0 h (control 0 h), control t = 3 h
(control 3 h) and isoproterenol (iso 3 h) heart. Reverse transcription and PCR were performed as described. An ethidium bromide-
stained agarose gel of the reaction products is shown; the left and right traces indicate DNA standards (from the top (bp): 1114, 900,
692, 501).
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3.4. CK mRNA levels
Messenger RNAs of the CK system were measured
by use of quantitative PCR. The PCR products,
which were obtained using the conditions given in
Table 1, of B-CK, M-CK and sarcomeric mito-CK
mRNA are demonstrated in Fig. 2. The PCR prod-
ucts of a representative heart of each group are
shown. The PCR products are found in appropriate
size according to their length given in Table 1. There
was no di¡erence in the intensity of the GAPDH
signal among groups. The B-CK signal of the isopro-
terenol-stimulated heart is markedly more intense
than those of the control groups, whereas the M-
CK signal of the isoproterenol-stimulated heart ap-
pears less intense. Incorporation of K-[32P]dCTP was
used to allow for quanti¢cation of the PCR products
by phospho-imaging. To account for variations in
sample treatment and RNA preparation, normaliza-
tion to GAPDH mRNA PCR products measured in
the same sample as an internal standard was per-
formed [31,32]. Absolute values for GAPDH aver-
aged 87.1 þ 6.4 in the control 0 h group, 82.6 þ 5.6
in the control 3 h group and 82.1 þ 2.8 phospho-im-
age units in the isoproterenol 3 h group, and were
not signi¢cantly di¡erent among groups, supporting
the validity of this internal standard.
Quantitative PCR results are presented in Fig. 3.
No di¡erences were found between both control
groups, indicating stability of the preparation con-
cerning CK gene expression. B-CK mRNA values
of the isoproterenol group were increased V3-fold
in comparison to both control groups. The M-CK
mRNA levels of this group, on the other hand,
were signi¢cantly reduced by about 18%.
4. Discussion
This study demonstrates acute changes in CK
mRNA expression due to L-adrenergic stimulation,
which in part reproduced previously described e¡ects
on CK caused by chronic hemodynamic and meta-
bolic alterations with or without left ventricular hy-
pertrophy and failure. Both, an increase in B- and a
decrease in M-CK-mRNA was found in intact resid-
ual post-myocardial infarction ventricular tissue two
months following myocardial infarction [16]. A re-
duction of M-CK mRNA levels is described due to
acute ischemia in dog myocardium [36] and following
1 month of diabetic metabolic conditions [37] but
this stands in contrast to experiments using pressure
overload by aortic banding, in which increased M-,
B- and mito-CK-mRNA levels were found after
4 days [12]. Upregulation of B-CK mRNA is re-
ported in chronic volume overload due to mitral re-
gurgitation in dogs after 4 months [17], after the
onset of pacing-induced heart failure in dogs [14]
Fig. 3. CK gene expression of control groups at t = 0 (control 0 h) or 3 h (control 3 h) and after 3 h isoproterenol infusion (iso 3 h).
The CK-mRNA levels were determined by quantitative PCR and normalized to the respective levels of the GAPDH-mRNA.
*P6 0.05 versus control t = 0 and versus control t = 3 h (P6 0.025 for each of the two t-tests, according to the Bonferroni correction).
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and in response to pressure overload [12]. More pre-
vious studies investigated CK isoenzyme activity
changes in response to cardiac injury. An increase
in B-subunit-containing isoform activity is found
due to left ventricular hypertrophy induced by renal
hypertension in the dog [13] and by aortic banding in
the rat [10,11,13], due to LAD occlusion [15] and due
to volume overload induced by aortocaval ¢stula in
the dog [14].
All these studies investigated the in£uence of he-
modynamic alterations on CK isoenzyme gene ex-
pression or CK activity and were performed in whole
animal models. Here, the occurrence of left ventric-
ular hypertrophy and/or heart failure is accompanied
by the activation of local and systemic neurohumoral
mechanisms, such as the renin-angiotensin, sympa-
thetic or endothelin systems. Furthermore, changes
in receptor distribution as well as in post-receptor
signaling may occur during development of left ven-
tricular hypertrophy and heart failure in chronic
models. For these reasons these previous studies
are limited in their ability to identify single humoral
stimuli which may induce the changes in CK isoen-
zyme gene expression.
The present study focused on the e¡ects of L-ad-
renergic stimulation. An isolated heart model was
selected to examine the e¡ects of the L1/L2-adrenergic
agonist isoproterenol independent from other circu-
lating mediators. L-Adrenergic stimulation has been
studied previously concerning its e¡ect on proto-on-
cogene expression and subsequent involvement in
cardiac hypertrophy. Several studies in whole ani-
mals and in cell culture report an increase in cardiac
protein synthesis 60 min and an increase in proto-
oncogene expression as short as 15^30 min after the
onset of L-adrenergic stimulation [38^41]. Proto-on-
cogene induction is likely to contribute to the regu-
lation of transcription of cardiac-speci¢c genes such
as the CK-isoenzyme genes and may precede the in-
duction or suppression of these genes [42,43]. There-
fore, isoproterenol-induced changes in CK genes ex-
pression are expected to occur later than proto-
oncogene induction.
Continuous administration of isoproterenol over
3 h as performed in our study, therefore, was re-
garded as feasible to induce changes of CK gene
expression in the isolated heart preparation. Perfu-
sion with red cell suspension was performed to pro-
vide physiological coronary perfusion £ow rate. This
way endothelial stimulation and/or damage which
may occur due to high perfusion rates in crystalloid
perfused preparations are avoided. Furthermore, per-
fusion with red cell suspensions was expected to re-
duce extracellular edema formation. In the present
study, a measurable increase in extracellular £uid
during the 3 h protocol did not occur as indicated
by the unchanged wet-to-dry-weight ratio. There was
no release of intracellular enzymes (CK or alanine
aminotransferase) into the perfusate and no myocar-
dial lactate production ruling out signi¢cant cell
damage and anaerobic metabolism due to disturban-
ces in local perfusion. Disturbances of left ventricular
diastolic function did not occur as left ventricular
diastolic pressure remained constant during the 3 h
recording time. Also, heart rate was stable over the
3 h protocol. Left ventricular systolic and developed
pressure as well as coronary £ow, however, declined
by 38% and 30% during the protocol after being
stable for the ¢rst 90 min. Limited stability in systolic
performance is a problem that is commonly observed
in isolated heart protocols lasting more than 90 min.
Eberli et al. [33] used isolated red cell perfused rat
hearts in an 100 min protocol. They found a 9%
decrease in the left ventricular developed pressure
after 100 min in control experiments. This corre-
sponds to the present study in which a 9% decrease
was found at t = 90 min. In isolated red cell perfused
rabbit hearts, Eberli et al. [44] report a signi¢cant
14% and 32% decrease in left ventricular developed
pressure and coronary £ow after 180 min but not
lactate release, only minimal release of CK and ala-
nine aminotransferase and constant tissue ATP,
phosphocreatine and glycogen content. Despite the
changes in left ventricular developed pressure and
coronary £ow, they regarded the system as metabol-
ically stable [44]. Considering these data and the
present results, the late decrease in left ventricular
developed pressure and coronary £ow represents a
minor and unavoidable limitation of the study. As
there were no di¡erences in CK and GAPDH gene
expression between the 0 and 3 h control groups,
results of the study concerning isoproterenol-induced
changes in CK gene expression are una¡ected by the
decreased left ventricular developed pressure and
coronary £ow.
As isoproterenol is a non-selective L1/L2-receptor
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agonist and as myocardium contains both receptor
subtypes (in a approximate ratio of 80:20% [45]), the
present study does not answer the question whether
isoproterenol-induced changes in CK gene expression
are mediated via L1 and/or L2 activation. Both re-
ceptor subtypes belong to the G-protein coupled re-
ceptors [46]. Although there are di¡erences in the
degree of coupling between the L1- and L2-receptors
to the adenylate cyclase, the activation of L1- as well
as of L2-receptors results via stimulatory G-proteins
in adenylate cyclase activation and intracellular
cAMP formation (for review see [47]). Cellular
cAMP concentration may a¡ect gene expression via
the cAMP-response element (CRE), which has been
described for many genes [48]. L1- And L2-receptors
use the same cAMP-dependent signaling pathway. It
may be for this reason that most studies dealing with
L-adrenergically induced changes in gene expression
have used the a non selective compound such as iso-
proterenol and have not di¡erentiated between L1-
and L2-activation [38,41,49,50]. Some data, however,
suggest that the L-adrenergic induced hypertrophic
response in rat cardiomyocytes may mediated by
L2-receptor stimulation [51].
Previously, changes in CK-mRNA expression in
intact residual post myocardial infarction ventricular
tissue have been found to correspond to alterations
in CK isoenzyme distribution [16]. This was not
found in the present isolated heart model of acute
L-adrenergic stimulation. Gene expression involves
the following processes: (1) transcription of genomic
DNA into mRNA, (2) post-transcriptional mRNA
processing, (3) translation of the processed, cytoplas-
mic mRNA into the amino acid sequence, and (4)
post-translational regulation. The detected mRNA
represents processed, cytoplasmic mRNA. Therefore,
the observed discrepancy in alterations of mRNA
and speci¢c activity may be explained by a lag of
translation or by post-translational regulation, which
has been described in osteoblastic cells [52]. Possibly,
signi¢cant translation would require substantially
longer stimulation periods, and this can therefore
not be addressed using the present isolated heart
model.
As the CK isoenzyme switch from M-CK to B-CK
isoenzymes, i.e., the reappearance of a fetal CK pat-
tern, is described for many models of hypertrophy
and heart failure [9,53], the observed changes in
CK gene expression after 3 h of L-adrenergic stimu-
lation may be regarded as the initiation of the switch
to a fetal distribution. This switch has generally been
interpreted as an adaptive mechanism, making en-
ergy transduction by CK more e⁄cient [54] due to
lower Km of B-CK compared to M-containing iso-
enzymes. Due to its higher a⁄nity for ADP, the B-
containing enzymes may produce ATP more e¡ec-
tively than the MM-isoform [54]. This may be bene-
¢cial in situations of increased energy demand (i.e.,
L-adrenergic stimulation) or under the conditions of
reduced energy reserve in the failing heart [54].
Although B-CK activity only comprises a small per-
centage of total CK activity, changes in the B-CK
activity corresponding to the increase in B-CK ex-
pression may be relevant, as CK in the cardiomyo-
cyte is operating in a compartmentalized manner
[55]. This way, changes in B-CK activity, which
only result in small changes of whole cell CK isoen-
zyme distribution, may be highly relevant if the sub-
sarcolemmal compartment, which is dominated by B-
CK, is concerned. Unfortunately, no methodology is
currently available to measure compartmentalized re-
actant concentrations.
The present study demonstrates that L-adrenergic
stimulation, which caused increased B-CK and de-
creased M-CK mRNA expression, evokes changes
in the gene expression of functionally relevant myo-
cardial proteins. These isoproterenol-induced
changes in CK-gene expression are similar to changes
in the distribution of CK-isoenzyme activity which
are characteristic of failing and hypertrophied heart.
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